131I-Labeled gold nanoframeworks for radiotherapy-combined second near-infrared photothermal therapy of cancer-Reference-Cited by-同舟云学术

131I-Labeled gold nanoframeworks for radiotherapy-combined second near-infrared photothermal therapy of cancer

Published:2021 Issue:45 Volume:9 Page:9316-9323
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Cheng Danling¹,Gong Jiali²,Wang Peng³,Zhu Jingyi¹⁴^ORCID,Yu Ningyue¹,Zhao Jinhua²^ORCID,Zhang Qin⁵,Li Jingchao¹^ORCID

Affiliation:

1. Shanghai Key Laboratory of Lightweight Composite, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, P. R. China

2. Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P. R. China

3. Department of General Surgery, The Fifth People's Hospital of Jinan, 250022, P. R. China

4. School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, People's Republic of China

5. Institute of Translational Medicine, Shanghai University, Shanghai 200444, P. R. China

Abstract

Radionuclide 131I-labeled gold nanoframeworks (131I-AuNFs) are developed for radiotherapy-combined second near-infrared photothermal therapy of breast cancer.

Funder

Science and Technology Commission of Shanghai Municipality

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB02115J

Reference44 articles.